These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9536925)

  • 1. Angiotensin-converting enzyme inhibition does not correct early defects in renal and vascular permeability in diabetes mellitus.
    Zietse R; Derkx FH; Weimar W; Schalekamp MA
    Clin Sci (Lond); 1998 Feb; 94(2):165-73. PubMed ID: 9536925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
    Vervoort G; Hertenberg F; Wetzels JF; Smits P
    J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus.
    Zietse R; Derkx FH; Weimar W; Schalekamp MA
    J Am Soc Nephrol; 1995 Jun; 5(12):2057-66. PubMed ID: 7579054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
    Rousso P; Buclin T; Nussberger J; Décosterd LA; La Roche SD; Brunner-Ferber F; Brunner HR; Biollaz J
    J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients.
    Fioretto P; Frigato F; Velussi M; Riva F; Muollo B; Carraro A; Brocco E; Cipollina MR; Abaterusso C; Trevisan M
    Am J Hypertens; 1992 Nov; 5(11):837-46. PubMed ID: 1457087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of atrial natriuretic factor during control of the renin-angiotensin system in anesthetized dogs.
    Seymour AA; Mazack EK
    Circ Res; 1988 Mar; 62(3):506-14. PubMed ID: 2830044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure.
    Abassi Z; Haramati A; Hoffman A; Burnett JC; Winaver J
    Am J Physiol; 1990 Jul; 259(1 Pt 2):R84-9. PubMed ID: 2142862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effects of angiotensin converting inhibitor and alpha-1-antagonist on albuminuria in insulin-dependent diabetes mellitus patients with nephropathy.
    Holdaas H; Hartmann A; Berg KJ; Langberg H; Blystad L; Fauchald P
    J Intern Med; 1995 Jan; 237(1):63-71. PubMed ID: 7830033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
    Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P
    Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
    Tikkanen I; Tikkanen T; Cao Z; Allen TJ; Davis BJ; Lassila M; Casley D; Johnston CI; Burrell LM; Cooper ME
    J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term treatment with ramipril normalizes renal haemodynamics and the natriuretic response to a sodium load in type 1 diabetic patients with early nephropathy.
    Stenvinkel P; Bolinder J; Alvestrand A
    Acta Diabetol; 1997 Mar; 34(1):10-7. PubMed ID: 9134051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine-induced blood pressure rise and renal vasoconstriction are not attenuated by enalapril treatment in microalbuminuric IDDM.
    Hoogenberg K; Navis G; Dullaart RP
    Nephrol Dial Transplant; 1998 Mar; 13(3):640-5. PubMed ID: 9550640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capillary permeability is increased in normo- and microalbuminuric type 1 diabetic patients: amelioration by ACE-inhibition.
    Oomen PH; Jager J; Hoogenberg K; Dullaart RP; Reitsma WD; Smit AJ
    Eur J Clin Invest; 1999 Dec; 29(12):1035-40. PubMed ID: 10583451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WITHDRAWN: Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
    Lovell HG
    Cochrane Database Syst Rev; 2007 Jul; (1):CD002183. PubMed ID: 17636698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atrial natriuretic peptide infusion on kidney function in normotensive type 1 (insulin-dependent) diabetic patients before and after enalapril treatment.
    Trevisan R; Giorato C; Fioretto P; Orrasch M; Opocher G; Mantero F; Tiengo A; Nosadini R; Pica B; Antonini P
    J Hypertens Suppl; 1991 Dec; 9(6):S390-1. PubMed ID: 1840200
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition by quinapril blocks the albuminuric effect of atrial natriuretic peptide in Type 1 diabetes and microalbuminuria.
    McKenna K; Smith D; Barrett P; Glenn A; Kesson CM; Connell J; Thompson CJ
    Diabet Med; 2000 Mar; 17(3):219-24. PubMed ID: 10784227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
    Lovell HG
    Cochrane Database Syst Rev; 2000; (2):CD002183. PubMed ID: 10796871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
    Lovell HG
    Cochrane Database Syst Rev; 2001; (1):CD002183. PubMed ID: 11279757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
    Navarro JF; Milena FJ; Mora C; León C; Claverie F; Flores C; García J
    Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.